4.8 Article

Cell type-specific targeting dissociates the therapeutic from the adverse effects of protein kinase inhibition in allergic skin disease

Related references

Note: Only part of the references are listed.
Review Immunology

Neutrophils, from Marrow to Microbes

Niels Borregaard

IMMUNITY (2010)

Article Immunology

Keratinocyte-Associated B7-H1 Directly Regulates Cutaneous Effector CD8+ T Cell Responses

Patcharee Ritprajak et al.

JOURNAL OF IMMUNOLOGY (2010)

Article Multidisciplinary Sciences

Requirement of CCL17 for CCR7-and CXCR4-dependent migration of cutaneous dendritic cells

Susanne Stutte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Allergy

Toll-like receptor 2 is important for the TH1 response to cutaneous sensitization

Haoli Jin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Article Immunology

Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity

Stefan F. Martin et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Article Biotechnology & Applied Microbiology

Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells

Patcharee Ritprajak et al.

MOLECULAR THERAPY (2008)

Review Immunology

Exploring the full spectrum of macrophage activation

David M. Mosser et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Immunology

Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen

Michele L. Caton et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Review Cell Biology

MAPKAP kinases - MKs - two's company, three's a crowd

M Gaestel

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Article Immunology

Anthrolysin O and other gram-positive cytolysins are Toll-like receptor 4 agonists

JM Park et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)